MIR4755

Across TCGA pan-cancer cohorts, MIR4755 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR4755’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR4755 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4755 is over-expressed in tumor, although a few such as KICH and LUSC show the opposite, repressed pattern.

STAD, KICH, and LUSC are the cancer types where MIR4755 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4755 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	+0.696	.004	4	view →
KICH	Male	II,III,IV	−0.588	.016	3	view →
LUSC	All	All	−0.343	.003	3	view →
HNSC	All	III,IV	+0.170	.020	2	view →
BLCA	Female	III,IV	+0.795	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MIR4755–STAD

Open the STAD breakdown →